[go: up one dir, main page]

AU1953701A - Methods and compositions for treatment of inflammatory disease - Google Patents

Methods and compositions for treatment of inflammatory disease

Info

Publication number
AU1953701A
AU1953701A AU19537/01A AU1953701A AU1953701A AU 1953701 A AU1953701 A AU 1953701A AU 19537/01 A AU19537/01 A AU 19537/01A AU 1953701 A AU1953701 A AU 1953701A AU 1953701 A AU1953701 A AU 1953701A
Authority
AU
Australia
Prior art keywords
compositions
treatment
methods
inflammatory disease
inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU19537/01A
Inventor
Bruce Levin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU1953701A publication Critical patent/AU1953701A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22—Cysteine endopeptidases (3.4.22)
    • C12Y304/22002—Papain (3.4.22.2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU19537/01A 1999-12-09 2000-12-08 Methods and compositions for treatment of inflammatory disease Abandoned AU1953701A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16984599P 1999-12-09 1999-12-09
US60169845 1999-12-09
PCT/US2000/033239 WO2001041783A1 (en) 1999-12-09 2000-12-08 Methods and compositions for treatment of inflammatory disease

Publications (1)

Publication Number Publication Date
AU1953701A true AU1953701A (en) 2001-06-18

Family

ID=22617432

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19537/01A Abandoned AU1953701A (en) 1999-12-09 2000-12-08 Methods and compositions for treatment of inflammatory disease

Country Status (2)

Country Link
AU (1) AU1953701A (en)
WO (1) WO2001041783A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10032132A1 (en) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermal therapeutic system containing non-steroidal anti-inflammatory drugs with selective COX-2 inhibition
US20030114416A1 (en) * 2001-08-14 2003-06-19 Pharmacia Corporation Method and compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate
US20030114418A1 (en) * 2001-08-14 2003-06-19 Pharmacia Corporation Method for the treatment and prevention of pain and inflammation with glucosamine and a cyclooxygenase-2 selective inhibitor and compositions therefor
ITMI20030210A1 (en) * 2003-02-07 2004-08-08 Res & Innovation Soc Coop A R L ENDOCANNABINOID-SIMILAR COMPOUNDS AND THEIR USE
US8034796B2 (en) 2004-04-07 2011-10-11 The University Of Georgia Research Foundation, Inc. Glucosamine and glucosamine/anti-inflammatory mutual prodrugs, compositions, and methods
CA2561672A1 (en) 2004-04-07 2005-12-08 The University Of Georgia Research Foundation, Inc. Glucosamine and glucosamine/anti-inflammatory mutual prodrugs, compositions, and methods
US8906966B2 (en) 2006-07-13 2014-12-09 Paul Sherwood Medicaments containing panthenol
EP2178526A1 (en) * 2007-07-13 2010-04-28 Prototype Bioforum Limited Injectable pharmaceutical compositions containing panthenol
CN102348482B (en) 2009-01-12 2014-05-14 科学与工业研究委员会 Process for preparation of hexadecyl cis-9-tetradecenoate and hexadecyl cis-10-tetradecenoate
US20110039928A1 (en) * 2009-08-13 2011-02-17 Golini Jeffrey M Cetylated fatty acid and alkali buffered creatine anti-inflammatory composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3860702A (en) * 1972-07-11 1975-01-14 Schuyler Dev Corp Anti-inflammatory compositions
US4049824A (en) * 1976-05-03 1977-09-20 Harry Weldon Diehl Cetyl myristoleate
US5874479A (en) * 1991-03-01 1999-02-23 Warner-Lambert Company Therapeutic permeation enhanced-wound healing compositions and methods for preparing and using same
US5260066A (en) * 1992-01-16 1993-11-09 Srchem Incorporated Cryogel bandage containing therapeutic agent
AU762102B2 (en) * 1998-04-16 2003-06-19 Thomas Dosumu-Johnson Method for the treatment of asthma
US6417227B1 (en) * 1999-04-28 2002-07-09 Cg And Associates Methods of delivery of cetyl myristoleate

Also Published As

Publication number Publication date
WO2001041783A1 (en) 2001-06-14

Similar Documents

Publication Publication Date Title
WO2003034984A9 (en) Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
AUPR638101A0 (en) Composition and method for treatment of disease
AU3998400A (en) Methods of treating c1s-mediated diseases and conditions, and compounds and compositions therefor
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2495200A (en) Compositions and methods for the treatment of tumor
AUPQ415899A0 (en) Compositions for and methods of treatment of allergic diseases
AU7748000A (en) Method and composition for the treatment of dermatologic diseases
AU7743100A (en) Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
AUPP968699A0 (en) Therapeutic compositions and method for their preparation
AU3632600A (en) Compositions and methods for the treatment of immune related diseases
AU6386499A (en) Method and composition for treatment of inflammatory bowel disease
IL155174A0 (en) Methods and compositions for the treatment of inflammatory diseases
AUPQ201499A0 (en) Treatment of inflammatory and malignant diseases
AU1953701A (en) Methods and compositions for treatment of inflammatory disease
AU4515001A (en) Compositions and methods for locally treating inflammatory diseases
AU2001267404A1 (en) Novel compounds for the treatment of inflammatory and cardiovascular diseases
AU3434601A (en) Compositions and methods for the treatment of immune related diseases
AU4228000A (en) Methods and compositions for the treatment and prevention of lung disease
AU2001232345A1 (en) Compositions for preventing and treating digestive diseases
AU2001255730A1 (en) Methods and compositions for the treatment of cardiac indications
AU3356000A (en) L-arginine based formulations for treating diseases and methods of using same
AU4839100A (en) Methods of using and compositions comprising n-desmethylzolpidem

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase